Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation11See Editorial by van Zonneveld and Rabelink, p. 2037  by Ruan, Xiong Z. et al.
Kidney International, Vol. 60 (2001), pp. 1716–1725
Dysregulation of LDL receptor under the influence of
inflammatory cytokines: A new pathway for
foam cell formation1
XIONG Z. RUAN, ZAC VARGHESE, STEPHEN H. POWIS, and JOHN F. MOORHEAD
Centre for Nephrology, Royal Free and University College Medical School, University College London, London, England,
United Kingdom
Dysregulation of LDL receptor under the influence of inflam- plasma-derived LDL-cholesterol and regulates plasma
matory cytokines: A new pathway for foam cell formation. LDL concentrations [1, 2]. Brown and Goldstein ob-
Background. Lipid-mediated renal injury is an important served that LDL receptor activity is under tight meta-component of glomerulosclerosis and its similarity to athero-
bolic control from intracellular cholesterol concentrationsclerosis is well described. This study focused on the relation-
through a feedback system [2]. This system maintains aship between lipid-mediated injury and inflammation by exam-
ining the role of inflammatory cytokines in the regulation of constant level of cholesterol in hepatocytes and other
human mesangial cell low-density lipoprotein (LDL) receptors. cells by controlling both the rate of cholesterol uptake
Methods. A human mesangial cell line (HMCL) was used from LDL and the rate of cholesterol synthesis [1].to study the effects of tumor necrosis factor- (TNF-) and
Therefore, native LDL is ineffective in generating lipidinterleukin-1 (IL-1) on the regulation of LDL receptor mRNA
rich foam cells that are precursors of fatty streaks. Inand protein in the presence of a high concentration of native
LDL (250 g/mL). contrast, modified LDL (oxidized or glycosylated) con-
Results. Native LDL caused foam cell formation in HMCL tributes to atherogenesis through its uncontrolled uptake
in the presence of antioxidants, TNF- and IL-1. Both cyto-
via scavenger receptors.kines overrode LDL receptor suppression induced by a high
Intracellular cholesterol regulates LDL receptor geneconcentration of LDL and increased LDL uptake by enhancing
receptor expression. These cytokines also caused increased transcription through the LDL receptor promoter, which
expression of SCAP [sterol responsive element binding protein contains three imperfect direct repeats of 16 bp and two
(SREBP) cleavage activation protein], and an increase in the TATA-like sequences of 7 bp each. Repeats one and
nuclear translocation of SREBP, which induces LDL receptor
three have some homology with the GC-rich region thatexpression.
binds a transcription-activator protein termed SP-1, andConclusion. These observations demonstrate that inflam-
matory cytokines can modify cholesterol-mediated LDL recep- repeat 2 is a sterol regulatory element (SRE-1) binding
tor regulation in mesangial cells, permitting unregulated intra- point. The sterol regulatory element binding proteins,
cellular accumulation of unmodified LDL and causing foam cell SREBP-1 and SREBP-2, are central molecules in the
formation. These findings suggest that inflammatory cytokines
cholesterol feedback system. In sterol-depleted cells, acontribute to lipid-mediated renal damage, and also may have
two-step cleavage process releases the NH2-terminal seg-wider implications for the study of inflammation in the athero-
sclerotic process. ment of SREBP, which then enters the nucleus, binds to
LDL receptor promoter region, and activates gene tran-
scription [3]. The process begins when a protease cuts
The low-density lipoprotein receptor (LDLr) is the SREBP-2 at site 1, which is at or near an arginine in the
primary receptor for binding and internalization of luminal loop, thereby separating the two membrane-span-
ning segments. This allows a second protease to cut the
protein at site 2, which is in the middle of the first trans-
1 See Editorial by van Zonneveld and Rabelink, p. 2037 membrane segment, releasing the N-terminal domain into
the cytosol. The site 1 protease, which is strictly regulatedKey words: glomerulosclerosis, human mesangial cells, lipoprotein, tu-
mor necrosis factor-, interleukin-1. by sterols, is active in sterol-depleted cells and turned
off when sterol accumulates. The site 2 protease is notReceived for publication September 15, 2000
regulated directly by sterols, but can act only after the site 1and in revised form April 30, 2001
Accepted for publication June 22, 2001 protease. SREBP cleavage-activating protein (SCAP)
has recently been identified in the hamster and in humans 2001 by the International Society of Nephrology
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as a key molecule [4] in the regulation of cholesterol 5% fetal calf serum (FCS), 2 mmol/L glutamine, 100 unit/
mL penicillin, 100 g/mL streptomycin, 2.5 g/mL am-metabolism by stimulating cleavage of SREBP-1 and -2.
It has multiple membrane-spanning regions, five of which photericin, 5 g/mL insulin, 5 g/mL human transferrin,
and 5 ng/mL sodium selenite. For the primary cultureresemble the sterol-sensing domain of 3-hydroxy-3-methyl-
glutaryl coenzyme A (HMGCo-A) reductase, an endo- of HMCs, above culture medium was used with 20%
FCS. All experiments were carried out in serum-freeplasmic reticulum enzyme whose degradation is acceler-
ated by sterols. A mutation at codon 443 of SCAP RPMI-1640 medium containing 0.2% bovine serum albu-
min (BSA) with the anti-oxidants ethylenediaminetetra-enhances the cleavage-stimulating ability of SCAP and
renders LDL receptor in Chinese hamster ovary (CHO) acetic acid (EDTA) and butylated hydroxytoluene
(BHT) at final concentrations of 100 and 20 mol/L,cells resistant to inhibition by sterols suggesting that
SCAP may be a key factor in the feedback regulation respectively (Sigma, Poole, Dorset, UK). All reagents
for cell culture were obtained from Gibco BRL (Paisley,of LDL receptor [4]. Therefore, SCAP appears to act as
a “cholesterol sensor” in mammalian cells [4, 5]. UK). Recombinant TNF- (2.0 to 5.0  107 U/mg) and
IL-1 (1.0 to 3.3  108 U/mg) were obtained from R&DWe have previously established that mesangial cells are
closely related to vascular smooth muscle cells and have Systems (Europe Ltd., Abingdon, UK).
both LDL receptor and scavenger receptors [6, 7]. Many
Preparation of lipoproteinof the histological features of progressive glomerular and
tubulointerstitial renal disease and chronic renal trans- Plasma was collected from healthy human volunteers
and LDL was isolated by sequential ultracentrifugationplant dysfunction share molecular mechanisms that are
considered important in the pathogenesis of atheroscle- [12]. The extent of lipid peroxidation of the LDL was es-
timated as the concentration of thiobarbituric acid reac-rosis [8]. The term “glomerular atherosclerosis” has been
proposed on the basis of these observations. Recent ex- tive substances (TBARS) as described previously [6] and
the results expressed as nmol of malondialdehyde per mgperimental evidence suggests that inflammation is an ag-
gravating factor in atherogenesis [9]. Elevated plasma lev- LDL (nmol MDA/mg LDL). The levels of TBARS in na-
tive LDL used in the study were less than 0.1 nmol MDA/els of cytokines including tumor necrosis factor- (TNF-),
transforming growth factor- (TGF-), platelet-derived mg LDL. LDL labeled with 1,1-dioctadecyl-3,3,3,3-tetra-
methylindocarbocyanine perchlorate (DiI-LDL) was ob-growth factor (PDGF) and interleukin-1 (IL-1) also have
been found in various kidney diseases, suggesting that tained from Biogenesis (Poole, UK).
inflammatory cytokines may contribute to glomerulo-
Morphological examinationsclerosis [10, 11]. However, the mechanism by which
inflammation leads to glomerular atherosclerosis is un- Human mesangial cell lines were plated in chamber
slides for tissue culture (Nunc Inc., Naperville, IL, USA)clear. Our recent work has shown that TNF-, TGF-,
PDGF, and IL-1 increase LDL receptor gene expression and incubated in serum-free RPMI-1640 medium with na-
tive LDL or cytokines plus native LDL in the absencethrough a sterol- and proliferation-independent gene tran-
scription pathway in a human mesangial cell (HMC) line. or presence of 250 g/mL of polyinosinic acid (PolyI)
or 5 mg/mL of heparin. After 24 hours of incubation, theThis suggests that inflammatory cytokines may increase
accumulation of cholesterol through the dysregulation cells were washed three times with phosphate-buffered
saline (PBS), fixed for 30 minutes with 5% formalin so-of LDL receptor in human mesangial cells, which may
be important in the progression of renal dysfunction [12]. lution in PBS, stained with Oil Red O for 30 minutes and
counterstained with hematoxylin for another five minutes.In this study, we investigated the molecular mechanisms
by which inflammatory cytokines increase LDL receptor Finally, the cells were examined by light microscopy.
expression in the presence of a maximally suppressive
Cell labeling and flow cytometric analysisconcentration of unmodified native LDL.
Human mesangial cell lines were incubated in serum-
free medium alone or with 50 ng/mL of TNF- or 5 ng/mL
METHODS
of IL-1 in the absence or presence of a high concentra-
Cell culture tion of native LDL (250 g/mL) for 24 hours, respec-
tively, then the medium was replaced by fresh serum-An established stable human mesangial cell line cells
(HMCL) was used in all experiments (kindly donated free medium containing 10 g/mL DiI-labeled LDL for
five hours at 37C. The cells were detached from the platesby Dr. J.D. Sraer, Hoˆpital Tenon, Paris, France). HMCs
were immortalized by transfection with T-SV40 and by incubation with 0.5% trypsin-EDTA and fixed in 5%
formalin solution in PBS. The fixed cells were washedH-ras oncogene, retaining many of the morphological
and physiological features of normal HMCs [12, 13]. three times in PBS and analyzed by fluorescence-acti-
vated cell sorter analysis (FACS) using a flow cytometerThese cells were cultured in growth medium containing
Roswell Park Memorial Institute RPMI-1640 medium, (Coulter, EPICS XL-MCL). Forward angle and 90 light
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scatter gates were established to exclude dead cells and (PE Applied Biosystems Ltd., Warrington, Cheshire, UK).
cell debris from the analysis. Fluorescence signals from The RT reaction was set up in a 20L mixture containing
the accumulated DiI in the cells were collected at 555 50 mmol/L KCl, 10 mmol/L Tris/HCl, 5 mmol/L MgCl2,
to 600 nm by a photomultiplier, converted to digital for- 1 mmol/L of each dNTPs, 2.5 mol/L random hexamers,
mat and processed for storage and display in one-param- 20 U RNAsin, and 50 U of Moloney-murine leukemia
eter log scale frequency histograms. Five thousand cells virus (M-MLV) reverse transcriptase. Incubations were
were analyzed in each sample. The data were evaluated performed in a DNA Thermal Cycler (Perkin-Elmer
by mean fluorescence intensity (MFI). Autofluorescence 9600) for 10 minutes at room temperature, followed by
signals from unlabeled cells were used as negative con- 30 minutes at 42C and 5 minutes at 99C. After cDNA
trols in each experiment. The MFI of the DiI-labeled synthesis by RT, the incubation mixture was split into
cells was calculated by subtracting the autofluorescence two 10-L aliquots for separate amplification of the
intensity from the observed MFI of labeled cells. The SCAP cDNA and the GAPDH cDNA using specific
average of the duplicate determination was used for sta- primers. SCAP 5 primer (nucleotide position 2574 to
tistical analyses, and each experiment was carried out in 2595); GCCCTCCGCCGCCTTCCCTCTT, 3 primer
duplicate. (nucleotide position 2933-2953); GCTGCTCCGCCCC
ACCACGAT [4]. GAPDH: 5 primer (nucleotide po-
Northern blot analysis
sition 73 to 92) TCATAGACAAGATGGTGAAG, 3
Total RNA was isolated from cultured HMCL by the primer (nucleotide position 303 to 327) TGACGGGAT
guanidinium method. For Northern blot analysis, 20 g CTCGCTCCTGGAAGAT. For PCR, the final concen-
of total RNA were denatured with formaldehyde and trations of the PCR reaction mixture were 50 mmol/L
electrophoresed in 1% agarose gel in the presence of KCl, 10 mmol/L Tris/HCl, 2 mmol/L MgCl2, 200 mol/L
formaldehyde. The RNA was transferred to nylon mem- dNTPs, 0.125 mol/L of primers, 1.25 U Taq DNA poly-
branes (Boehringer Mannheim, East Sussex, UK) by merase. After incubation for 145 seconds at 95C, 26 cycles
capillary blotting with 20  standard sodium citrate were performed for 30 seconds at 95C, 30 seconds at
(SSC) for 18 hours and fixed by UV irradiation. For 65C, and 60 seconds at 72C. Twenty microliters of each
hybridization, a fragment of the LDL receptor cDNA PCR reaction were subjected to electrophoresis in a 2%
probe, and as control, glyceraldehyde phosphate dehy- agarose gel.
drogenase (GAPDH) cDNA were used. The LDL recep-
tor cDNA probe (2.8 kb) was prepared by digesting the Southern blot analysis and quantitative evaluation
plasmid pLDLR3 (American Type Culture Collection,
Nucleic acids were transferred to a nylon membrane
Rockville, MD, USA) with the restriction endonucleases
(Boehringer Mannheim, Lewes, East Sussex, UK) using
HindIII and SmaI. The GAPDH cDNA probe (0.8 Kb)
the Southern analysis method. These membranes werewas prepared by digesting plasmid pHcGAP (American
probed with [-32P]ATP (3,000 Ci/mmol, Amersham, Lit-Type Culture Collection, Rockville, MD, USA) with the
tle Chalfont, Buckinghamshire, UK)-labeled oligonucleo-restriction endonucleases Pst I and Xba I. The cDNA
tides. The SCAP probe (nucleotide position 2654 to 2676):probes were labeled with 32P-dCTP (3000 Ci/mmol; Amer-
GGGCTGAGTGGGCTGTGAGGA [4] and GAPDHsham, Buckinghamshire, UK) by nick translation. The
probe (nucleotide position 170 to 191): AATGAAGGGlabeled probes were separated from unincorporated nu-
GTCGTTGATGGCA were labeled using 5-end labelingcleotides by Sephadex G-50 columns (Pharmacia, Herts,
system (Promega, Southampton, Hampshire, UK). Mem-UK). Prehybridization with cDNA probes were per-
branes were irradiated by UV Stratalinker for 3 minutes,formed in prehybridization buffer [5  SSPE, 5  Den-
prehybridized in 50% formamide, 5  Denhardt’s solu-hardt’s, 100 g/mL hsDNA (herring sperm DNA), 50%
tion, 5SSPE, 100g/mL hsDNA (herring sperm DNA),deionized formamide] for two hours at 42C. The blots
50 mmol/L sodium phosphate (pH 6.8) at 42C for 4 hours,were hybridized in hybridization buffer (the same as the
and hybridized overnight at 42C with at least 1  106prehybridization buffer except that 1  Denhardt’s was
cpm/mL of the labeled probe in the same solution as forused) overnight at 42C. The filters were washed twice
prehybridization but without Denhardt’s reagents. Thefor 5 minutes in 2  SSC with 0.1% sodium dodecyl
membranes were washed twice for 15 minutes at roomsulfide (SDS) at room temperature, followed by two 15-
temperature with 5  SSC, and then washed for 10 min-minute high stringency washes in 0.1  SSC containing
utes at 42C with 5  SSC. The blots were exposed to0.1% SDS at 68C.
x-ray films (Eastman Kodak, Rochester, NY, USA) for
RT-PCR four hours. Relative radiation density (the ratio of SCAP
to GAPDH) was calculated for each sample to adjustTotal RNA (500 ng) was used as a template for the
for the differences in RNA mass between templates andreverse transcription-polymerase chain reaction (RT-
PCR). All reagents were obtained from Perkin-Elmer was used for the quantitative comparisons.
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Fig. 1. Visualization of low-density lipoprotein (LDL) uptake and lipid droplets in a human mesangial cell line (HMCL) after tumor necrosis
factor- (TNF-) or interleukin-1 (IL-1) treatment. HMCLs were incubated for 24 hours in serum-free medium with 250 g/mL of native LDL
in the absence (A) or presence of 50 ng/mL of TNF- (B), 5 ng/mL of IL-1 (C), TNF- plus Poly I (D), IL-1 plus Poly I (E), TNF- plus
heparin (F), and IL-1 plus heparin (G). The cells were examined for lipid inclusions by Oil Red O staining. The results are typical of those
observed in four separate experiments (400).
Preparation of nuclear fraction 350 mA for one hour in 25 mmol/L Tris, pH 8.3, 192
mmol/L glycine, 0.1% SDS and 20% methanol. The mem-To prepare nuclear extracts, cells from duplicate 75
brane was then blocked with 3% blocker (Bio-Rad Labo-cm2 culture flasks were pooled and allowed to swell at
ratories, Herts, UK) for one hour at room temperature4C for 30 minutes in 1.5 mL of buffer A [10 mmol/L
followed by two five-minute washes in PBST (phosphate-HEPES, pH 7.9, 10 mmol/L KCl, 1.5mmol/L MgCl2, 0.5
buffered saline/1% Tween-20). The membrane was incu-mmol/L dithiothreitol (DTT), 0.4% NP-40, 0.5 mol/L
bated with rabbit anti-human SREBP-1 polyclonal anti-phenylmethylsulfonyl fluoride (PMSF), and 1 g/mL of
body (1 g/mL; Santa Cruz Biotechnology) for one hourantipain, laupeptin, bestatin, and chymostatin], and then
in antibody dilution buffer (1% BSA in PBST) followedpassed through a 23 gauge needle 20 times before centrif-
by two five-minute washes in PBST. A goat anti-rabbitugation at 1000  g at 4C for 7 minutes. The 1000  g
HRP-labeled antibody (Bio-Rad Laboratories) was di-pellet was resuspended in 60 L of buffer B (20 mmol/L
luted in antibody dilution buffer, then added to the mem-HEPES pH 7.9, 0.42 mol/L NaCl, 1.5 mmol/L MgCl2 brane for one hour followed by two five-minute washes in25% glycerol, 0.2 mmol/L EDTA, 0.5 mmol/L DTT, 0.5
PBST. Finally, amplification and colorimetric detection
mol/L PMSF, 2 mmol/L benzamidine and 1 g/mL of
procedures were performed using a Bio-Rad Opti-4CN
antipain, laupeptin, bestatin, and chymostatin). The sus- detection Kit (Bio-Rad Laboratories).
pension was passed through a 23 gauge needle 20 times,
incubated for 30 minutes at 4C, then centrifuged at 13,000 Data analysis
rpm in a microcentrifuge for 15 minutes at 4C. The super- In all experiments, groups of data were evaluated for
natant from this spin was used as the nuclear extract. significance by one-way analysis of variance (ANOVA)
using Minitab software. Data were considered significantWestern blot analysis for SREBP-1
if the P value  0.05.
Identical amounts of total protein from nuclear ex-
tracts were denatured, then subjected to electrophoresis
RESULTSon a 5% stacking and 8% separating SDS polyacrylamide
gel in a Bio-Rad mini Protein II apparatus. Electropho- Experiments were performed to determine whether
LDL is able to cause foam cell formation in the presenceretic transfer to nitrocellulose was accomplished at 100 V,
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TNF- (50 ng/mL) and IL-1 (5 ng/mL) increased LDL
uptake by HMCL in the presence of a high concentration
of native LDL and anti-oxidants (100 mol/L of EDTA
and 20 mol/L BHT; Fig. 3). These observations suggest
that TNF, and to a greater extent IL-1, overrode the
LDL receptor protein suppression induced by a high
concentration of native LDL.
We have previously examined LDL receptor promoter
activity using a reporter gene pGL3LDLR6500 in HMCL
[12]. A high concentration of native LDL (250 g/mL)
markedly decreased promoter activity. However, TNF-
(50 ng/mL) and IL-1 (5 ng/mL) increased LDL receptor
promoter activity even in the presence of a high concen-
tration of native LDL [12]. The present study examined
LDL receptor mRNA expression in HMCL cultured in
a high concentration of native LDL (250 g/mL), LDL
with TNF- (50 ng/mL) or IL-1 (5 ng/mL). Both cyto-
kines significantly increased LDL receptor mRNA ex-
pression, even in the presence of a high concentration
of native LDL (Fig. 4). This result suggests that inflam-
matory cytokines increase LDL receptor expression at
a transcriptional level, even in the presence of high con-
centrations of cholesterol.
Sterol regulatory element binding proteins SREBPs
are central molecules in the control of LDL receptor regu-
lation. SREBP-1 translocation was investigated from the
cytoplasm to the cell nucleus in the presence of LDL
Fig. 2. Electrophoretic mobility of LDL from the culture medium. and inflammatory cytokines. Nuclear SREBP-1 was de-
HMCL were incubated for 24 hours in serum-free RPMI-1640 medium
tected by the SREBP-1–specific polyclonal antibody us-with 250 g/mL of native LDL in the absence (A) or presence of
100 mol/L of EDTA and 20 mol/L of BHT (B) for the indicated ing Western blotting. A high concentration of LDL (200
time periods. The supernatants were collected and subjected to electro- g/mL) decreased SREBP-1 level in the nucleus in a time-
phoresis in Beckman Paragon LIPO Gel. Lane 1, fresh native LDL
dependent manner. However, both inflammatory cyto-(negative control); lane 2, Ox-LDL (positive control); lane 3, 0 hour
incubation with HMCL; lane 4, 24 hours; lane 5, 48 hours; lane 6, 72 kines TNF- (50 ng/mL) and IL-1 (5 ng/mL) increased
hours; lane 7, 96 hours. the level of nuclear SREBP-1 in the presence of a high
concentration of LDL (Fig. 5).
Finally, the mRNA expression of SCAP in HMCL
was examined under the influence of high concentrationsof cytokines. Staining of HMCL with Oil Red O before
of cholesterol. Cholesterol depletion up-regulated SCAP(Fig. 1A) and after 50 ng/mL of TNF- (Fig. 1B) and
expression, whereas high concentrations of native LDL5 ng/mL of IL-1 (Fig. 1C) stimulation in the presence
down-regulated SCAP mRNA expression in a time-of a high concentration of native LDL (250 g/mL) and
dependent manner (Fig. 6). This suggests that intracellu-antioxidants (100 mol/L of EDTA and 20 mol/L BHT)
lar concentrations of cholesterol affect SCAP expressionshowed that both cytokines increased the number of
at the transcriptional level and that SCAP is a cholesterolintracellular Oil Red O-stained lipid droplets. This pro-
sensor that regulates LDL receptor expression in HMCL.cess was not inhibited by polyinosinic acid (Poly I), which
We also showed that LDL down-regulated SCAP mRNAblocks scavenger receptors (Fig. 1 D, E) [14], but was
expression in a dose-dependent manner in both HMCLprevented by heparin, which removes LDL bound to the
and primary cultures of HMC (Fig. 7.). TNF- and IL-1cell surface (Fig. 1 F, G) [15]. The electrophoretic mobility
increased SCAP mRNA expression in HMCL in a doseof LDL from the culture medium was the same as that
responsive manner, even in the presence of high concen-of fresh LDL excluding the participation of oxidized
trations of cholesterol (Fig. 8). These results indicateLDL and scavenger receptor (Fig. 2). This also suggested
that overexpression of SCAP may be an important factorthat anti-oxidants were unable to prevent foam cell for-
in overriding the suppression of native LDL receptormation in the presence of inflammatory cytokines.
induced by high concentrations of cholesterol throughThe influence of cytokines on the regulation of LDL
receptor expression was examined by flow cytometry. the cleavage of SREBP-1.
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Fig. 3. Analysis of the mean fluorescence in-
tensity (MFI) in the TNF-- or IL-1-treated
HMCL. HMCL were incubated in serum-free
medium alone or with 50 ng/mL of TNF- or
5 ng/mL of IL-1 in the absence or presence
of a high concentration of native LDL (250g/
mL) for 24 hours. The medium was then re-
placed by fresh serum-free medium containing
10 g/mL DiI-labeled LDL for 5 hours at
37C. The cells were analyzed by FACS. MFI
was calculated by subtracting the autofluore-
scence intensity from the observed MFI of
labeled cells (B). Results represent means 	
SD of duplicate wells from four experiments.
*P 
 0.05 vs. control.
DISCUSSION polyinosinic acid and heparin are not specific blockers
of scavenger and LDL receptor respectively, they haveIn vivo, foam cell formation was firstly described in
been widely used in the study of oxidized or native LDLmacrophages. During the development of the lesions
binding and internalization. Additionally, all experimen-of atherosclerosis, monocytes became adherent to the
tal incubation media contained the antioxidants EDTAsurface of the endothelium, migrated subendothelially,
and BHT, both of which powerfully prevent oxidationand accumulated lipid [16]. In the kidney, the formation
of LDL by HMCL. The electrophoretic mobility of LDLof glomerular foam cells is encountered in renal glomer-
from the culture medium was the same as that of freshuli in cases of nephrotic syndrome and in renal allografts
LDL, indicating that no oxidation had taken place during[17]. It is generally accepted that lipid-laden cells identi-
the experiments. Therefore, there was no ligand for scav-fied by Oil Red O staining in vitro are the equivalent of
enger receptors in the culture medium. Taken together,foam cells.
these results imply that foam cell formation occurredOur previous studies showed that the inflammatory
through the dysregulation of the LDL receptor.cytokines TNF-, TGF-, PDGF, and IL-1 increased
In the classic pathway of cholesterol homeostasis, cho-LDL receptor gene expression in HMC by a sterol- and
lesterol is the major regulatory element. Intracellularproliferation-independent gene transcription pathway in
levels of cholesterol control the uptake and synthesis ofa human mesangial cell line [12]. Using the Oil Red
cholesterol through feedback regulation [1]. The evi-O staining technique, the present studies extend these
dence presented in our study, together with our previousobservations to show that feedback regulation prevents
studies of promoter activity [12], show that normal feed-native LDL from causing foam cell formation when
back regulation is preserved in HMCL in culture, demon-HMCL are incubated with native LDL. However, TNF-
strating the functional integrity of the LDL receptor.and IL-1 override the suppression of LDL receptor
The present study provides experimental evidence toinduced by a high concentration of LDL. The process
suggest that inflammatory cytokines may independentlyby which TNF- and IL-1 increased the number of
modulate LDL receptor function. Therefore, it appearsintracellular Oil Red O-stained lipid droplets in HMCL
that the normally tight sterol-dependent feedback LDLcould not be inhibited by Poly I, which blocks scavenger
receptor regulation in HMC is ineffective under the in-receptors [14], but was blocked by heparin, which re-
fluence of TNF- and IL-1. Thus native LDL can bemoves LDL bound to the cell surface [15], implying LDL
taken up in excess via LDL receptors to convert HMCLreceptor pathway involvement and effectively excluding
the participation of scavenger receptor. Although both into foam cells.
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which enter the nucleus and promote LDL receptor tran-
scription.
Our observations demonstrate a potential new path-
way for foam cell formation and suggest an important
mechanism through which inflammation might potenti-
ate lipid-mediated glomerular injury. This provides a pos-
sible explanation for the observation that abnormal glo-
merular deposition of LDL cholesterol is found in various
inflammatory renal diseases [18]. Nevertheless, foam cell
formation is not always a recognized feature of glomerulo-
nephritis, possibly because the pathogenesis of glomerulo-
nephritis and glomerulosclerosis is complex. Foam cell
formation may be an early event that is easily missed,
especially since routine de-fatting of renal biopsy samples
destroys foam cell appearance. Additionally, foam cells
may be difficult to find in the final stages of glomerulo-
sclerosis because of matrix expansion and fibrosis. Our
data also emphasize that foam cell formation may be
influenced by the underlying inflammatory milieu within
the kidney, which varies in different disease states and
at different times. This possibility clearly merits further
investigation. Finally, our findings may partly explain
the ineffectiveness of cholesterol-lowering strategies in
arresting the progression of renal disease.
Recent studies have linked systemic infection and in-
flammation with atherosclerosis [9, 19, 20]. Furthermore,
local inflammation occurs at the site of plaque formation.
Patients with elevated levels of acute-phase reactants
have a less favorable clinical course than those with nor-
mal levels of acute-phase reactants. Acute-phase re-
Fig. 4. Inflammatory cytokines overrode the LDL receptor mRNA actants are elevated in many chronic diseases; for exam-
suppression induced by a high concentration of native LDL. HMCL
ple, Janssen et al reported that C-reactive protein (CRP)were incubated in serum-free medium alone (control) or with 50 ng/mL
of TNF- or 5 ng/mL of IL-1 in the absence or presence of 250 g/mL and complement C3a levels are significantly raised in
of native LDL for 24 hours. (A) LDL receptor mRNA expression was patients with IgA nephropathy [21].examined using Northern blotting as described in the Methods section.
Our current understanding of the association between(B) Means	 SD of the densitometric scans of the LDL receptor mRNA
band from three experiments, normalized by comparison with GAPDH inflammation and atherosclerosis is primarily based on
mRNA, and expressed as a percentage of control. *P
 0.05 vs. control
“the response to injury hypothesis,” which suggests thatLDL group; **P 
 0.001 vs. control.
inflammation causes endothelial injury and mediates he-
modynamic damage [22]. However, the observations we
have reported suggest that inflammatory cytokines can
We also investigated the molecular mechanisms by modify cholesterol homeostasis through the dysregula-
which inflammatory cytokines overrode the normal cho- tion of the LDL receptor. Such dysregulation would per-
lesterol-mediated suppression of the LDL receptor by mit uncontrolled accumulation of LDL within cells. In
examining the expression of human SCAP. The high ex- the kidney, this process may specifically contribute to
pression of SCAP mRNA in sterol-depleted HMCL was progressive renal disease and chronic renal transplant
suppressed by high concentrations of LDL, suggesting dysfunction. In arteries, the same process may result in
that SCAP contributed to LDL receptor regulation by atherosclerosis. The implications of these findings are
acting as a cholesterol sensor. Both inflammatory cyto- that inflammatory cytokines are risk factors for athero-
kines TNF- and IL-1 increased SCAP mRNA expres- genesis, and that no cholesterol concentration is “safe”
sion in the presence of high concentrations of LDL. This in the presence of acute or chronic inflammation. There-
result suggests that inflammatory cytokines are able to fore, anti-inflammatory drugs may be useful therapeutic
regulate SCAP expression at a transcriptional level. Up- agents in addition to anti-oxidants and cholesterol-low-
ering drugs.regulation of SCAP stimulates cleavage of SREBPs,
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Fig. 5. Inflammatory cytokines increased ste-
rol-responsive element binding protein (SREBP)
cleavage in the human mesangial cell line
(HMCL). HMCL were incubated in serum-
free medium or serum-free medium con-
taining 200 g/mL of LDL in the presence of
50 ng/mL of TNF- or 5 ng/mL of IL-1 for
0 (control), 24, 48, and 72 hours. The nuclear
extracts were prepared and subjected to SDS-
PAGE, followed by immunoblot analysis. (A)
The SREBP-1 protein level was examined us-
ing Western blotting as described in the Meth-
ods section. (B) Means 	 SD of the densito-
metric scans of the SREBP-1 protein bands
from three experiments and expressed as a
percentage of control. Symbols are: ( ) LDL;
() TNF-  LDL; ( ) IL-1  LDL. *P 

0.05 vs control, **P 
 0.001vs control.
Fig. 6. Intracellular concentrations of choles-
terol regulated SREBP cleavage activation
protein (SCAP) mRNA expression in a time-
dependent manner in HMCL. HMCL were
incubated in serum-free medium alone or se-
rum-free medium with 200 g/mL of LDL for
0 (control), 4, 8, 24, 48, and 72 hours. (A)
SCAP mRNA expression was examined using
RT-PCR followed by Southern blotting as de-
scribed in the Methods section. (B) Means 	
SD of the densitometric scans of the SCAP
mRNA band from three experiments, normal-
ized by comparison with GAPDH mRNA, and
expressed as a percentage of control. *P
 0.05
vs. control, **P 
 0.001 vs. control.
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Fig. 7. Intracellular concentrations of choles-
terol regulated SCAP mRNA expression in a
dose-responsive manner in both HMCL and
primary culture of HMC. Both HMCL and
HMC were cultured serum-free medium (con-
trol) or serum-medium containing various
concentrations of native LDL (0, 12.5, 25, 50,
100, and 200 g/mL) for 24 hours. (A) SCAP
mRNA expression was examined using RT-
PCR followed by Southern blotting as de-
scribed in the Methods section. (B): The
means 	 SD of the densitometric scans of the
SCAP mRNA band from three experiments,
normalized by comparison with GAPDH
mRNA, and expressed as a percentage of con-
trol. *P 
 0.001 vs. control.
Fig. 8. Inflammatory cytokines increased SCAP
mRNA expression in HMCL. HMCL were in-
cubated in serum-free medium alone (control)
or with 200 g/mL of native LDL in the ab-
sence or presence of various concentrations
of TNF- or IL-1 for 24 hours. (A) SCAP
mRNA expression was examined using RT-
PCR followed by Southern blotting as de-
scribed in methods. (B) Means 	 SD of the
densitometric scans of the SCAP mRNA band
from three experiments, normalized by com-
parison with GAPDH mRNA, and expressed
as a percentage of control. *P 
 0.05 vs.
control  LDL group, **P 
 0.05 vs. control.
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